APA (7th ed.) Citation

J, G., L, H., J, S., K, B., R, B., T, H., . . . L, G. (2023). Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy. Advances in therapy, 40(10), 4189. https://doi.org/10.1007/s12325-023-02601-2

Chicago Style (17th ed.) Citation

J, Goldschmidt, et al. "Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy." Advances in Therapy 40, no. 10 (2023): 4189. https://doi.org/10.1007/s12325-023-02601-2.

MLA (9th ed.) Citation

J, Goldschmidt, et al. "Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy." Advances in Therapy, vol. 40, no. 10, 2023, p. 4189, https://doi.org/10.1007/s12325-023-02601-2.